Trial intelligence / Profile preview

Naltrexone and Neural Activity During Social Acceptance

NCT02818036Completed

Start
Aug 2016
Primary completion
Jun 2018
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of naltrexone. Primary endpoints: Blood Oxygen-Level Dependent Activations at 1 hour and Self-reported Feelings of Connection at 2 hours. Started Aug 2016; status: completed.

02

Drugs

naltrexone

Beyond the preview

Go deeper on NCT02818036.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02818036.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call